Effects of ketamine, propofol, and ketofol on proinflammatory cytokines and markers of oxidative stress in a rat model of endotoxemia-induced acute lung injury

Acta Biochimica Polonica

Volumn 60, Issue 3, 2013, Pages 451-456

  Gokcinar, Derya ^a   Ergin, Volkan ^b   Cumaoglu, Ahmet ^c   Menevse, Adnan ^b   Aricioglu, Aysel ^b  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

^c ERCIYES UNIVERSITY   (Turkey)

Author keywords

Acute lung injury; Ketamine; Ketofol; Lipopolysaccharide; Oxidative stress; Propofol

Indexed keywords

ANIMALIA; RATTUS;

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BIOLOGICAL MARKER; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; KETAMINE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROPOFOL; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL; ARTICLE; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; ENDOTOXEMIA; FEMALE; GENE EXPRESSION; GENETICS; INTRAVENOUS ADMINISTRATION; LIPID PEROXIDATION; LUNG; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; RAT; WISTAR RAT;

ACUTE LUNG INJURY; ADMINISTRATION, INTRAVENOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CYCLOOXYGENASE 2; DRUG COMBINATIONS; ENDOTOXEMIA; FEMALE; GENE EXPRESSION; INTERLEUKIN-1BETA; KETAMINE; LIPID PEROXIDATION; LIPOPOLYSACCHARIDES; LUNG; NITRIC OXIDE; OXIDATIVE STRESS; PROPOFOL; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885944211     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2013_2006     Document Type: Article

References (45)

1. Ahmad N, Chen LC, Gordon MA (2002) Regulation of cyclooxygenase-2 by nitric oxide in activated hepatic macrophages during acute endotoxemia. J Leukoc Biol 71:1005-1011.
2. Andolfatto G, Willman E (2010) A prospective case series of pediatric procedural sedation and analgesia in the emergency department using single-syringe ketamine-propofol combination (ketofol). Acad Emerg Med 17:194-201.
3. Ang SF, Sio SW, Moochhala SM (2011) Hydrogen sulfide upregulates cyclooxygenase-2 and prostaglandin e metabolite in sepsis-evoked acute lung injury via transient receptor potential vanilloid type 1 channel activation. J Immunol 187:4778-4787.
4. Baetz D, Shaw J, Kirshenbaum LA (2005)Nuclear factor-kappaB decoys suppress endotoxin-induced lung injury. Mol Pharmacol 67: 977-979.
5. Baeuerle PA (1998) I-kappaB-NF-kappaB structures:at the interface of inflammation control. Cell 95:729-731.
6. Barrientos-Vega R, Mar Sánchez-Soria M, Morales-García C, Robas-Gómez A, Cuena-Boy R, Ayensa-Rincon A (1997) Prolonged sedation of critically ill patients with midazolam or propofol:impact on weaning and costs. Crit Care Med 25:33-40.
7. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L et al. (1994) The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes and clinical trial coordination. Am J Respir Crit Care Med 149:818-824.
8. Blackwell TS, Christman JW (1997) The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol 17:3-9.
9. Bone RC, Grodzin CJ, Balk RA (1997) Sepsis:a new hypothesis for pathogenesis of the disease process. Chest 112:235-243.
10. Brierley J, Peters MJ (2008) Distinct hemodynamic patterns of septic shock at presentation to pediatric intensive care. Pediatrics 122: 752-759.
11. Brigham KL, Meyrick B (1986) Endotoxin and lung injury. Am Rev Respir Dis 133:913-927.
12. Callejas NA, Casado M, Díaz-Guerra MJ (2001) Expression of cyclooxygenase-2 promotes the release of matrix metalloproteinase-2 and -9 in fetal rat hepatocytes. Hepatology 33:860-867.
13. Chen RM, Chen TL, Lin YL, Chen TG, Tai YT (2005) Ketamine reduces nitric oxide biosynthesis in human umbilical vein endothelial cells by down-regulating endothelial nitric oxide synthase expression and intracellular calcium levels. Crit Care Med 33:1044-1049.
14. Chen TL, Chang CC, Lin YL, Ueng YF, Chen RM (2009) Signaltransducing mechanisms of ketamine-caused inhibition of interleukin-1 beta gene expression in lipopolysaccharide-stimulated murine macrophage-like Raw 264.7 cells. Toxicol Appl Pharmacol 240:15-25.
15. Coates D, Prys-Roberts C, Spelina KR, Monk CR, Norley I (1985) Propofol ('Diprivan') by intravenous infusion with nitrous oxide: dose requirements and haemodynamic effects. Postgrad Med J 61: 76-79.
16. da Silva FC, do Carmo de Oliveira Cito M, da Silva MI (2010) Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice. Brain Res Bull 83:9-15.
17. Gais P, Tiedje C, Altmayr F, Gaestel M, Weighardt H, Holzmann B (2010) TRIF signaling stimulates translation of TNF-alpha mRNA via prolonged activation of MK2. J Immunol 184:5842-5848.
18. Gao J, Zeng B, Zhou L, Yuan S, Zhang S (2003) Therapeutic effect of propofol in the treatment of endotoxin-induced shock in rats. J Huazhong Univ Sci Technolog MedSci 23:320-323.
19. Gao J, Zhao WX, Zhou LJ, Zeng BX, Yao SL, Liu D, Chen ZQ (2006) Protective effects of propofol on lipopolysaccharide-activated endothelial cell barrier dysfunction. Inflamm Res 55:385-392.
20. Gocan NC, Scott JA, Tym LK (2000) Nitric oxide produced via neuronal NOS may impair vasodilatation in septic rat skeletal muscle. Am J Physiol Heart Circ Physiol 278:1480-1489.
21. González-Correa JA, Cruz-Andreotti E, Arrebola MM (2008) Effects of propofol on the leukocyte nitric oxide pathway:in vitro and ex vivo studies in surgical patients. Naunyn Schmiedebergs Arch Pharmacol 376:331-319.
22. Gragasin FS, Bourque SL, Davidge ST (2013) Propofol increases vascular relaxation in aging rats chronically treated with the angiotensinconverting enzyme inhibitor captopril. Anesth Analg 116:775-783.
23. Huet O, Dupic L, Harrois A (2011) Oxidative stress and endothelial dysfunction during sepsis. Front Biosci 16:1986-1995.
24. Inada T, Kubo K, Shingu K (2010) Promotion of interferon-gamma production by naturalkiller cells via suppression of murine peritoneal macrophage prostaglandin E2 production using intravenous anesthetic propofol. Int Immunopharmacol 10:1200-1208.
25. Irifune M, Shimizu T, Nomoto M, Fukuda T (1992) Ketamine-induced anesthesia involves the N-methyl-d-aspartate receptor-channel complex in mice. Brain Res 596:1-9.
26. James R, Glen JB (1980) Synthesis, biological evaluation and preliminary structure-activity considerations of a series of alkylphenols as intravenous anesthetic agents. J Med Chem 23:1350-1357.
27. Karin M, Delhase M (2000) The I kappa B kinase (IKK) and NFkappa B:key elements of proinflammatory signalling. Semin Immunol 12:85-98.
28. Kawasaki T, Ogata M, Kawasaki C, Ogata J, Inoue Y, Shigematsu A (1999) Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro. Anesth Analg 89:665-669.
29. Khutia KS, Mandal CM, Das S, Basu SR (2012) Intravenous infusion of ketamine-propofol can be an alternative to intravenous infusion of fentanyl-propofol for deep sedation and analgesia in peadiatric patients undergoing emergency short surgical procedures. Indian J Anaesth 56:145-150.
30. Koga K, Ogata M, Takenaka I, Matsumoto T, Shigematsu A (1994) Ketamine suppresses tumor necrosis factor-alpha activity and mortality in carrageenan-sensitized endotoxin shock model. Circ Shock 44:160-166.
31. Lappi-Blanco E, Kaarteenaho-iik R, Maasilta PK (2006) COX-2 is widely expressed in metaplastic epithelium in pulmonary fibrous disorders. Am J Clin Pathol 126:717-724.
32. Larsen B, Hoff G, Wilhelm W, Buchinger H, Wanner GA, Bauer M (1998) Effect of intravenous anesthetics on spontaneous and endotoxin-stimulated cytokine response in cultured human whole blood. Anesthesiology 89:1218-1227.
33. Lasa M, Mahtani KR, Finch A, Brewer G, Saklatvala J, Clark AR (2000) Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol Cell Biol 20:4265-4274.
34. Liu FL, Chen TL, Chen RM (2012) Mechanisms of ketamine-induced immunosuppression. Acta Anaesthesiol Taiwan 50:172-177.
35. Liu YC, Chang AY, Tsai YC (2009) Differential protection against oxidative stress and nitric oxide overproduction in cardiovascular and pulmonary systems by propofol during endotoxemia. J Biomed Sci 15:16-18.
36. Loh G, Dalen D (2007) Low-dose ketamine in addition to propofol for procedural sedation and analgesia in the emergency department. Ann Pharmacother 41:485-492.
37. Ma L, Wu XY, Zhang LH, Chen WM, Uchiyama A, Mashimo T, Fujino Y (2013) Propofol exerts anti-inflammatory effects in rats with lipopolysaccharide-induced acute lung injury by inhibition of CD14 and TLR4 expression. Braz J Med Biol Res 46:299-305.
38. Marinelli WA, Ingbar DH (1994) Diagnosis and management of acute lung injury. Clin Chest Med 15:517-146.
39. Min TJ, Kim WY, Jeong WJ, Choi HJ, Lee SY, Kim HJ, Park CY (2012) Effect of ketamine on intravenous patient-controlled analgesia using hydromorphone and ketorolac after the Nuss surgery in pediatric patients. Korean J Anesthesiol 62:142-147.
40. Miranda KM, Espey MG, Wink DA (2001) A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5:62-71.
41. Murphy PG, Myers DS, Davies MJ, Webster NR, Jones JG (1992) The antioxidant potential of propofol (2,6-diisopropylphenol). Br J Anaesth 68:613-618.
42. Ogawa A, Uemura M, Kataoka Y, Ol K, Inokuchi T (1993) Effects of ketamine on cardiovascular responses mediated by N-methyl-Daspartate receptor in the rat nucleus tractus solitarius. Anesthesiology 93:163-167.
43. Okamoto I, Abe M, Shibata K (2000) Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture. Am J Respir Crit Care Med 162:716-722.
44. Randolph AG (2009) Management of acute lung injury and acute respiratory distress syndrome in children. Crit Care Med 37:2448-2454.
45. Zhao W, Liu M, Kirkwood KL (0000) p38 alpha stabilizes interleukin-6 mRNA via multiple AU-rich elements. J Biol Chem 283:1778-1785.